Isolation of a Novel Cyclic Hexadepsipeptide Pipalamycin from Streptomyces as an Apoptosis-inducing Agent.
-
- UCHIHATA YUKI
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University
-
- ANDO NORITAKA
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University
-
- IKEDA YOKO
- Institute of Microbial Chemistry
-
- KONDO SHINICHI
- Institute of Microbial Chemistry
-
- HAMADA MASA
- Institute of Microbial Chemistry
-
- UMEZAWA KAZUO
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University
Search this article
Abstract
The novel cyclic hexadepsipeptide named pipalamycin was isolated from a culture filtrate of Streptomyces sp. ML297-90F8 as an apoptosis-inducing agent. The antibiotic was found to be consisting of each one mole of alanine, N-hydroxyalanine, glycine, N-acylated 3-hydroxyleucine, and two moles of piperazic acid. Pipalamycin induced apoptosis in apoptosis-resistant human pancreatic adenocarcinoma AsPC-1 cells at 0.3μg/ml in 24-48 hours. It also showed antibacterial activity on Gram-positive bacteria such as Staphylococcus aureus and Micrococcus luteus. Fermentation, isolation, structural elucidation and the biological activities of pipalamycin are described.
Journal
-
- The Journal of Antibiotics
-
The Journal of Antibiotics 55 (1), 1-5, 2002
JAPAN ANTIBIOTICS RESEARCH ASSOCIATION